(Q38955193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

review article

1 reference

title

Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Ted K Yanagihara

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Heva J Saadatmand

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

8 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

397-411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632018%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-016-2270-2

23 March 2020

exact match

0 references

cites work

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Radiosurgery as part of the initial management of patients with malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Linac radiosurgery for high-grade gliomas: the University of Florida experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Gamma knife for glioma: selection factors and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Abscopal effect of radiation in papillary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Neoantigens in cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Abscopal effects of radiation therapy: a clinical review for the radiobiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Maximizing tumor immunity with fractionated radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Exploring the role of cancer stem cells in radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2270-2

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

21 January 2018

1 reference

12 December 2020

Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage

1 reference

12 December 2020

CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients

1 reference

12 December 2020

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

1 reference

12 December 2020

Radiation as an immunological adjuvant: current evidence on dose and fractionation.

1 reference

12 December 2020

PD-L1 expression and prognostic impact in glioblastoma

1 reference

12 December 2020

Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme

1 reference

12 December 2020

Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.

1 reference

12 December 2020

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

1 reference

12 December 2020

Radiation abscopal antitumor effect is mediated through p53

1 reference

12 December 2020

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha

1 reference

12 December 2020

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

1 reference

12 December 2020

Radiosurgery and accelerated radiotherapy for patients with glioblastoma.

1 reference

12 December 2020

Abscopal regression following radiotherapy for adenocarcinoma

1 reference

12 December 2020

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020